Manufacturing of recombinant adeno-associated viral vectors: new technologies are welcome

Molecular Therapy Methods and Clinical Development

Volumn 3, Issue , 2016, Pages 15049-

  Ayuso, Eduard ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR; ALIPOGENE TIPARVOVEC; CYCLIC GMP; POLYETHYLENEIMINE;

ARTICLE; BIOREACTOR; HEK293 CELL LINE; HUMAN; NONHUMAN; PRIORITY JOURNAL; ULTRACENTRIFUGATION; VIRAL GENE THERAPY;

EID: 85015659342     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2015.49     Document Type: Article

References (26)

1. 1 Maguire, AM, High, KA, Auricchio, A, Wright, JF, Pierce, EA, Testa, F, et al. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet 374 (2009), 1597–1605.
2. 2 Maguire, AM, Simonelli, F, Pierce, EA, Pugh, EN Jr, Mingozzi, F, Bennicelli, J, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358 (2008), 2240–2248.
3. 3 Bainbridge, JW, Smith, AJ, Barker, SS, Robbie, S, Henderson, R, Balaggan, K, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358 (2008), 2231–2239.
4. 4 Nathwani, AC, Tuddenham, EG, Rangarajan, S, Rosales, C, McIntosh, J, Linch, DC, et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 365 (2011), 2357–2365.
5. 5 Nathwani, AC, Reiss, UM, Tuddenham, EG, Rosales, C, Chowdary, P, McIntosh, J, et al. Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N Engl J Med 371 (2014), 1994–2004.
6. 6 MacLaren, RE, Groppe, M, Barnard, AR, Cottriall, CL, Tolmachova, T, Seymour, L, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase ½ clinical trial. Lancet 383 (2014), 1129–1137.
7. 7 Stroes, ES, Nierman, MC, Meulenberg, JJ, Franssen, R, Twisk, J, Henny, CP, et al. Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients. Arterioscler Thromb Vasc Biol 28 (2008), 2303–2304.
8. 8 Carpentier, AC, Frisch, F, Labbé, SM, Gagnon, R, de Wal, J, Greentree, S, et al. Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients. J Clin Endocrinol Metab 97 (2012), 1635–1644.
9. 9 Grieger, JC, Soltys, SM, Samulski, RJ, Production of recombinant adeno-associated virus vectors using suspension HEK293 cells and continuous harvest of vector from the culture media for GMP FIX and FLT1 clinical vector. Mol Ther, 2015, 10.1038/mt.2015.187.
10. 10 Srivastava, A, Lusby, EW, Berns, KI, Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol 45 (1983), 555–564.
11. 11 Sonntag, F, Köther, K, Schmidt, K, Weghofer, M, Raupp, C, Nieto, K, et al. The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. J Virol 85 (2011), 12686–12697.
12. 12 Hermonat, PL, Muzyczka, N, Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA 81 (1984), 6466–6470.
13. 13 Matsushita, T, Elliger, S, Elliger, C, Podsakoff, G, Villarreal, L, Kurtzman, GJ, et al. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther 5 (1998), 938–945.
14. 14 Xiao, X, Li, J, Samulski, RJ, Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72 (1998), 2224–2232.
15. 15 Wright, JF, Wellman, J, High, KA, Manufacturing and regulatory strategies for clinical AAV2-hRPE65. Curr Gene Ther 10 (2010), 341–349.
16. 16 Allay, JA, Sleep, S, Long, S, Tillman, DM, Clark, R, Carney, G, et al. Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial. Hum Gene Ther 22 (2011), 595–604.
17. 17 Chahal, PS, Schulze, E, Tran, R, Montes, J, Kamen, AA, Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery. J Virol Methods 196 (2014), 163–173.
18. 18 Ayuso, E, Mingozzi, F, Bosch, F, Production, purification and characterization of adeno-associated vectors. Curr Gene Ther 10 (2010), 423–436.
19. 19 Urabe, M, Ding, C, Kotin, RM, Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther 13 (2002), 1935–1943.
20. 20 Cecchini, S, Virag, T, Kotin, RM, Reproducible high yields of recombinant adeno-associated virus produced using invertebrate cells in 0.02- to 200-liter cultures. Hum Gene Ther 22 (2011), 1021–1030.
21. 21 Thorne, BA, Takeya, RK, Peluso, RW, Manufacturing recombinant adeno-associated viral vectors from producer cell clones. Hum Gene Ther 20 (2009), 707–714.
22. 22 Greenberg, B, Yaroshinsky, A, Zsebo, KM, Butler, J, Felker, GM, Voors, AA, et al. Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b). JACC Heart Fail 2 (2014), 84–92.
23. 23 Thomas, DL, Wang, L, Niamke, J, Liu, J, Kang, W, Scotti, MM, et al. Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells. Hum Gene Ther 20 (2009), 861–870.
24. 24 Flotte, TR, Trapnell, BC, Humphries, M, Carey, B, Calcedo, R, Rouhani, F, et al. Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results. Hum Gene Ther 22 (2011), 1239–1247.
25. 25 Mingozzi, F, Maus, MV, Hui, DJ, Sabatino, DE, Murphy, SL, Rasko, JE, et al. CD8(+) T-cell responses to adeno-associated virus capsid in humans. Nat Med 13 (2007), 419–422.
26. 26 Qu, G, Bahr-Davidson, J, Prado, J, Tai, A, Cataniag, F, McDonnell, J, et al. Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography. J Virol Methods 140 (2007), 183–192.